MBIO
Mustang Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.61M
P/E Ratio
—
EPS
$-0.38
Beta
2.18
52W High
$3.68
52W Low
$0.53
50-Day MA
$0.89
200-Day MA
$1.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Mustang Bio Inc
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.
Fundamentals
| Revenue (TTM) | -50,000 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-2.40M |
| Operating Margin | 0.00% |
| Return on Equity | -67.90% |
| Return on Assets | -11.30% |
| Revenue/Share (TTM) | $-0.00 |
| Book Value | $1.31 |
| Price-to-Book | 0.60 |
| Price-to-Sales (TTM) | 2205.73 |
| EV/Revenue | - |
| EV/EBITDA | -0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.73M |
| Float | $5.35M |
| % Insiders | 4.30% |
| % Institutions | 10.12% |
Data last updated: 4/8/2026